SAN DIEGO--(BUSINESS WIRE)--Mentor Capital, Inc. (OTCQB:MNTR) announced that Mentor’s Cannabis Index for Value Investors has gained 22% YTD during 2016. According to Mentor CEO, Chet Billingsley, “The index was boosted by GW Pharmaceuticals' (NASDAQ:GWPH) recent doubling after its cannabidiol drug for childhood epilepsy received a positive nod from the FDA.” The other leaders reported by Mentor in its marijuana index were indoor cultivation system experts Surna, Inc., (OTCQB:SRNA) at (326%) and new cannabis patent participant Mentor Capital at (354%), when compared to NASDAQ average unit sales, book value and growth set together at (100%).
“Because legal marijuana sales growth is largely a political reclassification from illegal to legal it is not surprising that there is great interest in the political changes this election cycle will bring within the cannabis operating and investment community. Speculations abound from Donald Trump coopting the youth vote and weeks of air time by backing legalization once he is past the primaries, to President Obama declassifying marijuana off of Schedule 1 as a swansong during his last days. Regardless, the political mode is for greater legalization. That momentum seems to support the observed growth in the legal cannabis market, and the index, at about 400% of the growth of NASDAQ,” reports the Mentor Capital CEO.
The other cannabis stocks and their respective ratios to NASDAQ in this value focused marijuana stock index are: Americann, Inc. (OTCQX:ACAN) at (58%); Digipath, Inc. (OTCQB:DIGP) at (162%); GW Pharmacueticals, Plc at (135%); Hemp, Inc. (OTCMkts:HEMP) at (98%), and Terra Tech Corp (OTCQX:TRTC) at (87%). The complete Index can be found at: www.MentorCapital.com.
About Mentor Capital: The Company seeks to come alongside and assist private medical marijuana and cannabis companies and their founders in meeting their liquidity and financial objectives, to add protection for investors and to help incubate private cannabis companies.
This press release is neither an offer to sell, nor a solicitation of offers to purchase, securities.
Forward Looking Statements: This press release contains forward-looking statements within the meaning of the federal securities laws, including statements concerning financial projections, financing activities, corporate combinations, product development activities and sales and licensing activities. Such forward-looking statements are not guarantees of future results or performance, are sometimes identified by words of condition such as “should,” “could,” “expects,” “may,” “intends,” “seeks,” “looks,” “moves,” or “plans” and are subject to a number of risks and uncertainties, known and unknown, that could cause actual results to differ materially from those intended or anticipated. Such risks include, without limitation: nonperformance of investments, partner and portfolio difficulties, potential delays in marketing and sales, problems securing the necessary financing to continue operations, problems involving continued illegality of cannabis products, potential of competitive products, services, and technologies, difficulties experienced in product development, in recruiting knowledgeable personnel and in protecting intellectual property. Further information concerning these and other risks is included in the Company’s 10-K and 10-Q filings including the Company’s most recent Quarterly Report on Form 10-Q for the quarter ended September 30, 2015 which, along with other very important information about the Company, can be found filed with the SEC and here:
http://mentorcapital.com/disclosures/
The Company undertakes no obligation to update or revise such forward-looking statements to reflect new information, events or circumstances occurring after the date of this press release.
